Sharing data for cancer research
Biblio
Data from: A validated Tumor Control Probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy. 2015. doi:10.17195/candat.2015.10.8. Walsh - TCP meta-analysis of patients treated with photon, proton and c-ion radiotherapy (CSV) (15.82 KB) Walsh - TCP meta-analysis of patients treated with photon, proton and c-ion radiotherapy (XLS) (13.85 KB)
Data from: Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicenter in silico ROCOCO trial. 2016. doi:10.17195/candat.2016.04.2.
Data from: Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicenter in silico ROCOCO trial. 2016. doi:10.17195/candat.2016.04.2.
Data from: Developing and validating a survival prediction model for NSCLC patients through distributed learning across three countries. 2017. doi:10.17195/candat.2017.02.2. Jochems-2017-MaastroDataUnbinned.csv (62.76 KB)
Data from: Developing and validating a survival prediction model for NSCLC patients through distributed learning across three countries. 2017. doi:10.17195/candat.2017.02.2. Jochems-2017-MaastroDataUnbinned.csv (62.76 KB)
PET imaging of hypoxia using [18F]HX4: a phase I trial. European Journal of Nuclear Medicine and Molecular Imaging. 2010;37(9):1663 - 1668. doi:10.1007/s00259-010-1437-x.
The posterior cerebellum, a new organ at risk?. Clinical and Translational Radiation Oncology. 2018;8:22 - 26. doi:10.1016/j.ctro.2017.11.010.
Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging. Proceedings of the National Academy of Sciences. 2011;108(35):14620 - 14625. doi:10.1073/pnas.1102526108.